Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as ...Show More
competitor of
Metrics
marketSTOCKS
msh_idCOM:INOVIO
localeus
websitehttp://www.inovio.com/
ipo_date1998-12-08
primary_stock_msh_idNASDAQ:INO
source_refdc10fd4d-8109-4da3-ae0c-2a948fe4fcb1
products_or_servicesDevelopment of DNA medicines for treating HPV-related diseases, cancer, and infectious diseases, along with proprietary delivery technology.